MedPath

Studying how daily changes, what you eat or drink, and exercise impact the measurement of body composition using a bioelectrical impedance analysis device

Not Applicable
Recruiting
Registration Number
JPRN-UMIN000052512
Lead Sponsor
Shinshu University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
40
Inclusion Criteria

Not provided

Exclusion Criteria

1. Individuals with a pacemaker. 2. Patients with intravital metal or silicon implants. 3. Patients with poorly controlled circulatory problems despite medication or other treatments. 4. Those experiencing orthopedic problems resulting in regular physical pain. 5. Patients with preexisting neurological diseases. 6. Individuals experiencing joint pain in the lower limbs during exercise. 7. Pregnant individuals or those who may be pregnant. 8. Those with known food allergies to any substance to be ingested. 9. Individuals otherwise deemed unsuitable as subjects by the principal investigator.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The primary outcome measures were skeletal muscle mass and body fat mass, obtained through multifrequency bioelectrical impedance analysis. Measurements were taken on each of the three experimental days at six-time points: immediately after the laboratory visit, post-experimental task (including water or food intake, or exercise), and at 30, 60, 90, and 120 minutes after the completion of the experimental task.
Secondary Outcome Measures
NameTimeMethod
Secondary outcomes encompass other body composition parameters such as body water content, mineral content, and protein content, as well as electrical resistance metrics including impedance, resistance, and phase angle, all obtained via multifrequency bioelectrical impedance analysis. Measurements will be conducted following the protocol outlined for the primary outcome. Additionally, age and gender will be recorded as general characteristics, and height and weight will be measured. Height will be assessed immediately after each experimental visit on all three experimental days, while weight will be measured in alignment with the primary outcome measurements.
© Copyright 2025. All Rights Reserved by MedPath